"Wolverine Clinical Trials is focused on researching new medications and therapies in order to improve the standard of our healthcare. As a dedicated multi-specialty clinical facility in Santa Ana, we have conducted a vast range of Phase I-IV studies in areas such as Dermatology, Psychiatry/Neurology, Gastroenterology, Gynecology, Hematology/Oncology, and more. We pride ourselves in providing each patient with exceptional medical care and professionalism. Call us now and help make a difference in the world of medicine today!"

During the past decade, Wolverine Clinical Trials, Llc conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 3 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wolverine Clinical Trials, Llc" #1 collaborator was "AbCellera Biologics Inc." with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "Shanghai Junshi Bioscience Co., Ltd." with 1 trials as a collaborator and "Vir Biotechnology, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Wolverine Clinical Trials, Llc" are "Dermatitis, Atopic" (2 trials), "Acne Inversa" (1 trials), "Arthritis" (1 trials), "Atopic Dermatitis" (1 trials) and "Autoimmune Diseases" (1 trials). Many other conditions were trialed in "Wolverine Clinical Trials, Llc" in a lesser frequency.

Most popular intervention types in "Wolverine Clinical Trials, Llc" are "Drug" (8 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Abrocitinib 200 mg" (2 trials), "Abrocitinib 100 mg" (1 trials), "Bamlanivimab" (1 trials) and "Bebtelovimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wolverine Clinical Trials, Llc" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Wolverine Clinical Trials, Llc". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Wolverine Clinical Trials, Llc, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Wolverine Clinical Trials, Llc, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".